Controlled Systemic Release of Therapeutic Peptides from PEGylated Prodrugs by Serum Proteases

Api88 Is a Novel Antibacterial Designer Peptide To Treat Systemic Infections with Multidrug-Resistant Gram-Negative Pathogens

(2012) Patricia Czihal et al.   ACS Chemical Biology

Novel Apidaecin 1b Analogs with Superior Serum Stabilities for Treatment of Infections by Gram-Negative Pathogens

(2012) Nicole Berthold et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oncocin derivative Onc72 is highly active against Escherichia coli in a systemic septicaemia infection mouse model

(2012) D. Knappe et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Rational Design of Oncocin Derivatives with Superior Protease Stabilities and Antibacterial Activities Based on the High-Resolution Structure of the Oncocin-DnaK Complex

(2011) Daniel Knappe et al.   CHEMBIOCHEM

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

(2010) Karthikeyan K Kumarasamy et al.   LANCET INFECTIOUS DISEASES

Emerging PEGylated drugs

(2009) Jung Seok Kang et al.   EXPERT OPINION ON EMERGING DRUGS

Releasable PEGylation of proteins with customized linkers

(2007) David Filpula et al.   ADVANCED DRUG DELIVERY REVIEWS